Published in PLoS One on January 22, 2010
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol (2010) 1.77
Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis. Biomaterials (2011) 1.32
Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis. J Exp Clin Cancer Res (2013) 1.07
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. Cancer Res (2013) 1.03
In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model. J Bone Miner Res (2013) 0.93
In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors. PLoS One (2012) 0.85
Modeling tumor microenvironments in vitro. J Biomech Eng (2014) 0.84
Chemical and physical properties of carbonated hydroxyapatite affect breast cancer cell behavior. Acta Biomater (2015) 0.83
Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols. Bonekey Rep (2016) 0.81
Protein-crystal interface mediates cell adhesion and proangiogenic secretion. Biomaterials (2016) 0.79
Osteotropic cancer diagnosis by an osteocalcin inspired molecular imaging mimetic. Biochim Biophys Acta (2013) 0.78
The use of porous scaffold as a tumor model. Int J Biomater (2013) 0.77
Modeling tumor microenvironments using custom-designed biomaterial scaffolds. Curr Opin Chem Eng (2016) 0.77
A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario? Oncotarget (2016) 0.76
Advances in multicellular spheroids formation. J R Soc Interface (2017) 0.75
Three-Dimensional Mechanical Loading Modulates the Osteogenic Response of Mesenchymal Stem Cells to Tumor-Derived Soluble Signals. Tissue Eng Part A (2016) 0.75
Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapies. Nat Commun (2017) 0.75
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Tensional homeostasis and the malignant phenotype. Cancer Cell (2005) 19.30
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med (2009) 13.74
Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer (2002) 12.45
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Mechanisms of bone metastasis. N Engl J Med (2004) 10.40
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell (2005) 9.18
Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (1992) 7.92
A tense situation: forcing tumour progression. Nat Rev Cancer (2009) 7.80
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol (2007) 7.38
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest (1999) 5.30
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Osteoblast adhesion on biomaterials. Biomaterials (2000) 4.34
Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med (2005) 4.27
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A (2005) 4.20
Engineering tumors with 3D scaffolds. Nat Methods (2007) 3.96
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest (1996) 3.44
Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer (2005) 2.86
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer (2008) 2.85
Molecular biology of bone metastasis. Mol Cancer Ther (2007) 2.71
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun (1998) 2.62
Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology (2000) 2.51
Mechanisms of bone metastasis. Cancer (1997) 2.29
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem (2000) 2.18
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer (2002) 2.16
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A (2009) 2.07
Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int (2002) 1.91
Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials (2005) 1.89
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor. J Biol Chem (2003) 1.81
Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia (2005) 1.75
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res (1997) 1.71
Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone (2003) 1.66
Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer (1997) 1.58
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res (2001) 1.57
Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryot Gene Expr (2000) 1.55
Regulation of osteoclast function. J Bone Miner Res (1997) 1.55
Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res (2007) 1.48
Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. Eur Cell Mater (2003) 1.46
Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J Biol Chem (2000) 1.46
Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism. PLoS One (2009) 1.40
Antitumor effects of bisphosphonates: promising preclinical evidence. Cancer Treat Rev (2008) 1.40
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. Mol Cancer Ther (2006) 1.29
Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res (2003) 1.28
Differences of bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating. Biomaterials (1996) 1.25
Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res (2005) 1.16
Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol Carcinog (2001) 1.14
Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line. Retrovirology (2008) 1.12
Metastatic breast cancer cells suppress osteoblast adhesion and differentiation. Clin Exp Metastasis (2004) 1.03
Breast cancer metastasis to bone: it is not all about PTHrP. Clin Orthop Relat Res (2003) 1.02
Nanostructured HA crystals up-regulate FGF-2 expression and activity in microvascular endothelium promoting angiogenesis. Bone (2007) 0.92
Osteoblast-derived TGF-beta1 stimulates IL-8 release through AP-1 and NF-kappaB in human cancer cells. J Bone Miner Res (2008) 0.92
Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate. Langmuir (2008) 0.92
Stimulation of cell proliferation by calcium and a calcimimetic compound. Endocrinology (1997) 0.91
Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-kappaB in human osteoblast-like cells. J Bone Miner Res (2003) 0.77
Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials (2010) 1.87
Integrated approach to designing growth factor delivery systems. FASEB J (2007) 1.35
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis. Biomaterials (2011) 1.32
Mechanical strain regulates endothelial cell patterning in vitro. Tissue Eng (2007) 1.26
Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng Part A (2010) 1.24
Microfluidic culture models of tumor angiogenesis. Tissue Eng Part A (2010) 1.23
Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci U S A (2012) 1.12
Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng (2006) 1.07
Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett (2004) 1.04
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. Cancer Res (2013) 1.03
Formation of microvascular networks in vitro. Nat Protoc (2013) 1.03
Parylene peel-off arrays to probe the role of cell-cell interactions in tumour angiogenesis. Integr Biol (Camb) (2009) 1.02
Stiffness of photocrosslinked RGD-alginate gels regulates adipose progenitor cell behavior. Biotechnol Bioeng (2011) 1.02
Integrin-adhesion ligand bond formation of preosteoblasts and stem cells in three-dimensional RGD presenting matrices. Biomacromolecules (2008) 0.97
Tissue-engineered three-dimensional tumor models to study tumor angiogenesis. Tissue Eng Part A (2010) 0.96
Physicochemical regulation of endothelial sprouting in a 3D microfluidic angiogenesis model. J Biomed Mater Res A (2013) 0.95
Engineered culture models for studies of tumor-microenvironment interactions. Annu Rev Biomed Eng (2013) 0.95
Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis. Lab Invest (2005) 0.94
In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model. J Bone Miner Res (2013) 0.93
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors. Cancer Discov (2013) 0.91
Multiscale models of breast cancer progression. Ann Biomed Eng (2012) 0.91
Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol Ther (2007) 0.89
Phosphorescent nanoparticles for quantitative measurements of oxygen profiles in vitro and in vivo. Biomaterials (2012) 0.89
Electrical control of protein conformation. Adv Mater (2012) 0.89
Electrical control of cell density gradients on a conducting polymer surface. Chem Commun (Camb) (2009) 0.86
Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells. Biochim Biophys Acta (2013) 0.85
Adipose-derived stem cells increase angiogenesis through matrix metalloproteinase-dependent collagen remodeling. Integr Biol (Camb) (2016) 0.82
Abstract 153: A Novel 3D Platform to Investigate Neoangiogenesis, Transendothelial Migration and Metastasis of Breast Cancer Cells. Plast Reconstr Surg (2014) 0.75